Current Use for Old Antibacterial Agents: Polymyxins, Rifamycins, and Aminoglycosides

被引:17
作者
Chen, Luke F. [1 ]
Kaye, Donald [2 ]
机构
[1] Duke Univ, Div Infect Dis & Int Hlth, Dept Med, Med Ctr, Durham, NC 27710 USA
[2] Drexel Univ, Dept Med, Coll Med, Philadelphia, PA 19102 USA
关键词
Rifaximin; Pharmacokinetics; Pharmacodynamics; Toxicity; Polymyxins; Aminoglycoside; Rifampin; VENTILATOR-ASSOCIATED PNEUMONIA; RESISTANT PSEUDOMONAS-AERUGINOSA; ONCE-DAILY TOBRAMYCIN; CYSTIC-FIBROSIS; IN-VITRO; STAPHYLOCOCCUS-AUREUS; ACINETOBACTER-BAUMANNII; CLOSTRIDIUM-DIFFICILE; INTRAVENOUS COLISTIN; SYNERGISTIC ACTIVITY;
D O I
10.1016/j.mcna.2011.03.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This article reviews three classes of antibacterial agents that are uncommonly used in bacterial infections and therefore can be thought of as special-use agents. The polymyxins are reserved for gram-negative bacilli that are resistant to virtually all other classes of drugs. Rifampin is used therapeutically, occasionally as a companion drug in treatment of refractory gram-positive coccal infections, especially those involving foreign bodies. Rifaximin is a new rifamycin that is a strict enteric antibiotic approved for treatment of traveler's diarrhea and is showing promise as a possible agent for refractory Clostridium difficile infections. The aminoglycosides are used mainly as companion drugs for the treatment of resistant gram-negative bacillary infections and for gram-positive coccal endocarditis.
引用
收藏
页码:819 / +
页数:26
相关论文
共 160 条
[71]   Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis [J].
Jiménez-Mejías, ME ;
Pichardo-Guerrero, C ;
Márquez-Rivas, FJ ;
Martín-Lozano, D ;
Prados, T ;
Pachón, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (03) :212-214
[72]   Interruption of recurrent Clostridium difficile -: Associated diarrhea episodes by serial therapy with vancomycin and rifaximin [J].
Johnson, Stuart ;
Schriever, Christopher ;
Galang, Minerva ;
Kelly, Ciaran P. ;
Gerding, Dale N. .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (06) :846-848
[73]   SINGLE, LARGE, DAILY DOSING VERSUS INTERMITTENT DOSING OF TOBRAMYCIN FOR TREATING EXPERIMENTAL PSEUDOMONAS PNEUMONIA [J].
KAPUSNIK, JE ;
HACKBARTH, CJ ;
CHAMBERS, HF ;
CARPENTER, T ;
SANDE, MA .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (01) :7-12
[74]   STAPHYLOCOCCUS-EPIDERMIDIS CAUSING PROSTHETIC VALVE ENDOCARDITIS - MICROBIOLOGIC AND CLINICAL OBSERVATIONS AS GUIDES TO THERAPY [J].
KARCHMER, AW ;
ARCHER, GL ;
DISMUKES, WE .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (04) :447-455
[75]   Emergence of drug resistance - Impact on bacterial meningitis [J].
Klugman, KP ;
Madhi, SA .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1999, 13 (03) :637-+
[76]  
KOBASA WD, 1983, REV INFECT DIS, V5, pS533
[77]   Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator-Associated Pneumonia: A Matched Case-Control Study [J].
Kofteridis, Diamantis P. ;
Alexopoulou, Christina ;
Valachis, Antonios ;
Maraki, Sofia ;
Dimopoulou, Dimitra ;
Georgopoulos, Dimitrios ;
Samonis, George .
CLINICAL INFECTIOUS DISEASES, 2010, 51 (11) :1238-1244
[78]   Comparative efficacies of rifaximin and vancomycin for treatment of Clostridium difficile-associated diarrhea and prevention of disease recurrence in hamsters [J].
Kokkotou, Eti ;
Moss, Alan C. ;
Michos, Athanasios ;
Espinoza, Daniel ;
Cloud, Jeffrey W. ;
Mustafa, Nasirna ;
O'Brien, Michael ;
Pothoulakis, Charalabos ;
Kelly, Ciardn P. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (03) :1121-1126
[79]   Polymyxin B: similarities to and differences from colistin (polymyxin E) [J].
Kwa, Andrea ;
Kosiakou, Sofia K. ;
Tam, Vincent H. ;
Falagas, Matthew E. .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (05) :811-821
[80]   Dose adjustment of the non-nucleoside reverse transcriptase inhibitors during concurrent rifampicin-containing tuberculosis therapy: one size does not fit all [J].
Kwara, Awewura ;
Ramachandran, Geetha ;
Swaminathan, Soumya .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (01) :55-68